[Redding, California] - Meticulous Research® has recently published a comprehensive report forecasting the Asia-Pacific Point-of-Care (PoC) Market to soar to $11.80 billion by 2030, demonstrating a robust Compound Annual Growth Rate (CAGR) of 7.5% from 2023 to 2030. This significant market expansion is primarily driven by the increasing prevalence of chronic diseases, continuous innovations in PoC testing technologies, and the scarcity of skilled laboratory technicians. However, market growth is tempered by pricing pressures stemming from fluctuating reimbursement rates. On the bright side, the growing preference among healthcare professionals for PoC tests over traditional laboratory tests is poised to unlock substantial market opportunities, despite the ongoing challenge of limited awareness about PoC devices.

Download Sample Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5671

Key Market Players

The key players operating in the Asia-Pacific Point-of-Care market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Trinity Biotech plc (Ireland), Werfen (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and bioMérieux S.A. (France).

Market Segmentation
The Asia-Pacific PoC market is segmented by:

Offering: Consumables, Instruments, Software, and Services
Platform: Lateral Flow Assays, Molecular Diagnostics, and Other Platforms
Application:
Blood Glucose Monitoring
Infectious Disease Testing (e.g., Parasitic Infections, Hepatitis, HIV, Respiratory Infections)
COVID-19 Testing
Tumor/Cancer Marker Testing
Pregnancy and Fertility Testing
Cardiac Marker/Cardiac Metabolism Testing
Cholesterol/Lipid Profile Testing
Coagulation Testing
Hematology
Drugs of Abuse Testing
Urinalysis
Other PoC Testing
Sample Type: Blood, Nasopharyngeal Swab, Urine, Saliva, and Other Sample Types
End User: Home Care/Self-Testing, Hospitals, Physician Offices & Ambulatory Care Settings, Diagnostic Laboratories, and Other End Users
Geography: Major countries include Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, and the Rest of Asia-Pacific
Market Insights
Offerings: In 2023, consumables are projected to dominate the market, driven by their repetitive use, advances in direct-to-consumer testing, and increased product approvals.
Platforms: Lateral flow assays are expected to lead, benefiting from new product launches, low development costs, and the surge in demand due to the COVID-19 pandemic.
Applications: Blood glucose monitoring will hold the largest market share, supported by the rising diabetes prevalence in Southeast Asia, which is projected to reach 113 million adults by 2030.
Sample Types: Blood samples are anticipated to represent the largest segment, attributed to the wide array of tests available for various chronic conditions.
End Users: Hospitals are set to be the largest segment, reflecting the extensive use of PoC devices across various departments and the global increase in healthcare expenditure.
Get Customize Report: https://www.meticulousresearch.com/request-customization/cp_id=5671

Regional Outlook
China is forecasted to hold the largest market share in 2023, propelled by a significant number of hospitals and diagnostic centers, along with robust support from both public and private sectors for advanced healthcare facilities.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research